Health Catalyst downgraded by KeyBanc Capital Markets
$HCAT
Computer Software: Programming Data Processing
Technology
KeyBanc Capital Markets downgraded Health Catalyst from Overweight to Sector Weight
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/18/2026 | $1.00 | Overweight → Equal Weight | Wells Fargo |
| 8/27/2025 | $4.00 | Overweight → Neutral | Piper Sandler |
| 8/11/2025 | Buy → Neutral | Citigroup | |
| 8/8/2025 | $4.00 | Overweight → Neutral | Cantor Fitzgerald |
| 6/17/2025 | Buy → Neutral | BTIG Research | |
| 4/9/2025 | Outperform → In-line | Evercore ISI | |
| 1/8/2025 | $9.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 4/10/2024 | Overweight → Sector Weight | KeyBanc Capital Markets |
Wells Fargo downgraded Health Catalyst from Overweight to Equal Weight and set a new price target of $1.00
Piper Sandler downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00
Citigroup downgraded Health Catalyst from Buy to Neutral
SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t
SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ126." A live audio webcast will be available online at https://ir.healthcatalyst.com/.
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Steve Nelson, Executive Vice President and President of Aetna, a CVS Health company, has been appointed to its Board of Directors, effective May 1, 2026. Nelson's appointment follows the naming of Ben Albert as CEO and Justin Spencer as Chairman of the Board earlier this year, continuing a deliberate pattern of leadership moves designed to accelerate the company's transformation– executing on a single, coordinated strategy to help health systems address cost, cli
4 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
DEFA14A - Health Catalyst, Inc. (0001636422) (Filer)
DEF 14A - Health Catalyst, Inc. (0001636422) (Filer)
PRE 14A - Health Catalyst, Inc. (0001636422) (Filer)
SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t
SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ126." A live audio webcast will be available online at https://ir.healthcatalyst.com/.
SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. "We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million," said Ben Albert, CEO of Health Catalyst "In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Steve Nelson, Executive Vice President and President of Aetna, a CVS Health company, has been appointed to its Board of Directors, effective May 1, 2026. Nelson's appointment follows the naming of Ben Albert as CEO and Justin Spencer as Chairman of the Board earlier this year, continuing a deliberate pattern of leadership moves designed to accelerate the company's transformation– executing on a single, coordinated strategy to help health systems address cost, cli
Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.
SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr. Arens collectively o
SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
SC 13G - Health Catalyst, Inc. (0001636422) (Subject)
SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)